Work

A phase I/II safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors

Year: 2017

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx376.049

Authors: M. Chenard-Poirier, D.S. Hong, R. Coleman, J. de Bono, M. Mau-Sorensen, D. Collins, S. Lisby, L. Basse, U. Lassen

Institutions: Institute of Cancer Research, Royal Marsden Hospital, The University of Texas MD Anderson Cancer Center, Copenhagen University Hospital, Royal Marsden NHS Foundation Trust, Genmab (Denmark), Rigshospitalet

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2761625702

FWCI: 0.42

Cites:

Cited by: 3

Related to: 10